Compliance Now
MARCH 8, 2022
Under the ACA, non-grandfathered group health plans must provide benefits for “preventive care” on a first-dollar basis. An update to the list of women’s contraceptives found in the FDA Birth Control Guide. By: Megan Diehl, Manager, Compliance Consulting, MZQ Consulting. no co-payments, co-insurance, or deductibles may be applied).
Compliance Now
JANUARY 20, 2022
The ACA requires non-grandfathered health plans to pay for “preventive care” on a first-dollar basis, meaning that no copays, coinsurance, or deductibles can be charged for certain services defined as “preventive” under these rules. By: Jessica Waltman, Principal, Forward Health Consulting. Contraceptives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 8, 2023
would likely skip receiving preventive health care services if the Affordable Care Act’s (ACA) coverage for them goes away, a Morning Consult survey found. One of the key benefits embedded in the ACA was “free” without co-pay shares for preventive care. Many health citizens in the U.S.
Bill of Health
SEPTEMBER 21, 2024
Food and Drug Administration (FDA), and Department of Health Human Services (HHS). It may very well be that deciding when an alpha amino acid polymer is a “protein” to be regulated by the FDA is not simply a question of statutory interpretation, but also a question of science and policy. Loper Bright overturned Chevron v.
Health Populi
JANUARY 9, 2020
For overall healthcare reform, the plurality of Americans prefer improving the current system (that is, building on the Affordable Care Act) versus repealing and replacing the ACA or adopting a Medicare for All plan.
Kaiser Health News
OCTOBER 7, 2024
han presionado a la Administración de Drogas y Alimentos (FDA) para que tome medidas que ayuden a eliminar la desviación racial en los oxímetros de pulso. Pero mientras la FDA trabajaba en un borrador de directrices, los médicos y los científicos no saben a qué atenerse.
Health Populi
AUGUST 16, 2019
Employers’ most daunting challenge and uncertainty when it comes to dealing with pharmacy spending is the specialty drug impact — specifically, new million-dollar therapies getting approved by the FDA. Much now depends on the U.S.
Expert insights. Personalized for you.
188 
Let's personalize your content